In vitro measurement of human T cell responses to Varicella Zoster Virus antigen

Archives of Virology, Supplement

Volumn , Issue 17, 2001, Pages 143-149

  Hayward, A R ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; VIRUS ANTIGEN;

ANIMAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOUSE; REVIEW; VARICELLA ZOSTER VIRUS; VIROLOGY;

ANIMALS; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; HERPESVIRUS 3, HUMAN; HUMANS; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MICE;

EID: 0035234985     PISSN: 09391983     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-3-7091-6259-0_15     Document Type: Article

References (30)

1. Arvin AM, Kinney-Thomas E, Shriver K, Grose C, Koropchak CM, Scranton E, Wittek AE, Diaz PS (1900) Immunity to varicella zoster virus glycoproteins gp 1 (90/58) and gp III (gp 118) and to a non-glycosylated protein, p170. J Immunol 137: 1346-1351
2. Arvin AM (1996) Immune responses to varicella-zoster virus. Infect Dis Clin North Am 10: 529-570
3. Butz EA, Bevan MJ (1998) Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity 8: 167-175
4. Cohen JI (1998) Infection of cells with varicella-zoster virus down-regulates surface expression of class I major histocompatibility complex antigens. J Infect Dis 177: 1390-1393
5. Flynn KJ, Belz GT, Altman JD, Ahmed R, Woodland DL, Doherty PC (1998) Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity 8: 683-691
6. Hayward A, Levin M, Wolf W, Angelova G, Gilden D (1991) Varicella-zoster virus-specific immunity after herpes zoster. J Infect Dis 163: 873-875
7. Hayward AR, Buda K, Jones M, White CJ, Levin MJ (1996) Varicella zoster virus-specific cytotoxicity following secondary immunization with live or killed vaccine. Viral Immun 9: 241-245
8. Hayward AR (1990) T cell response to predicted amphipathic peptides of varicella zoster virus glycoproteins II and IV. J Virol 64: 651-655
9. Hayward AR, Zerbe GO, Levin MJ (1994) Clinical application of responder cell frequency estimates with four years of follow up. J Immunol Methods 170: 27-36
10. Hayward A, Giller R, Levin M (1989) Phenotype, cytotoxic and helper functions of T cells from varicella zoster virus stimulated cultures of human lymphocytes. Viral Immun 2: 175-181
11. Hayward AR, Pontesilli O, Herberger M, Lazslo M, Levin M (1986) Specific lysis of VZV infected B lymphoblasts by human T cells. J Virol 58: 179-184
12. Hill A, Jugovic P, York I, Russ G, Bennink J, Yewdell J, Ploegh H, Johnson D (1995) Herpes simplex virus turns off TAP to evade host immunity. Nature 375: 411-415
13. Jenkins DE, Redman RL, Lam EM, Liu C, Lin I, Arvin AM (1998) Interleukin (IL)-10, IL-12, and interferon-gamma production in primary and memory immune responses to varicella-zoster virus. J Infect Dis 178: 940-948
14. Jenkins DE, Yasukawa LL, Benike CJ, Engleman EG, Arvin AM (1998) Isolation and utilization of human dendritic cells from peripheral blood to assay an in vitro primary immune response to varicella-zoster virus peptides. J Infect Dis 178 [Suppl 1]: 39-42
15. Jenkins DE, Yasukawa LL, Bergen R, Benike C, Engleman EG, Arvin AM (1999) Comparison of primary sensitization of naive human T cells to varicella-zoster virus peptides by dendritic cells in vitro with responses elicited in vivo by varicella vaccination. J Immunol 162: 560-567
16. Kawano S, Terada K, Hiraga Y, Morita T (1996) Immunogenicity of the whole antigen and glycoprotein I of varicella-zoster virus (VZV) and the VZV skin test antigen. Acta Paediatr Jpn 38: 121-123
17. Larsson M, Jin X, Ramratnam B, Ogg GS, Engelmayer J, Demoitie MA, McMichael AJ, Cox WI, Steinman RM, Nixon D, Bhardwaj N (1999) A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. AIDS 13: 767-777
18. Liu Y, Wehner RH, Zhao M, Nielsen PJ (1997) Distinct costimulatory molecules are required for the induction of effector and memory cytotoxic T lymphocytes. J Exp Med 185: 251-262
19. Murali-Krishna K, Altman JD, Suresh M, Sourdive DJ, Zajac AJ, Miller JD, Slansky J, Ahmed R (1998) Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8: 177-187
20. Ogg GS, Jin X, Bonhoeffer S, Dunbar PR, Nowak MA, Monard S, Segal JP, Cao Y, Rowland-Jones SL, Cerundolo V, Hurley A, Markowitz M, Ho DD, Nixon DF, McMichael AJ (1998) Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279: 2103-2106
21. Ogg GS, McMichael AJ (1999) Quantitation of antigen-specific CD8+ T-cell responses. Immunol Lett 66: 77-80
22. Pontesilli O, Carotenuto P, Levin MJ, Suez DJ, Hayward AR (1987) Processing and presentation of cell-associated varicella zoster antigens by human moncytes. Clin Exp Immunol 70: 127-135
23. Ridge JP, Di Rosa F, Matzinger P (1998) A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 393: 474-478
24. Rose DN, Schechter CB, Adler JJ (1995) Interpretation of the tuberculin skin test. J Gen Int Med 10: 635-642
25. Sadzot-Delvaux C, Arvin AM, Rentier B (1998) Varicella-zoster virus IE63, a virion component expressed during latency and acute infection, elicits humoral and cellular immunity. J Infect Dis 178 [Suppl 1]: 43-47
26. Stevenson PG, Doherty PC (1998) Kinetic analysis of the specific host response to a murine gammaherpesvirus. J Virol 72: 943-949
27. Takahashi M, Iketani T, Sasada K, Hara J, Kamiya H, Asano Y, Baba K, Shiraki K (1992) Immunization of the elderly and patients with collagen vascular diseases with live varicella vaccine and use of varicella skin antigen. J Infect Dis 166 [Suppl 1]: 58-62
28. Van Oers MH, Pinkster J, Zeujlemaker WP (1978) Quantification of antigen-reactive cells among human T lymphocytes. Eur J Immunol 8: 477-484
29. Zaia JA, Leary PL, Levin MJ (1978) Specificity of the blastogenic response of human mononuclear cells to herpesvirus antigens. Infect Immun 20: 646-651
30. Zhang Y, Cosyns M, Levin MJ, Hayward AR (1994) Cytokine production in varicella zoster virus stimulated limiting dilution lymphocyte cultures. Clin Exp Immunol 98: 128-133